BDBM304631 (S)-(4-(4-((4,4-dimethylcyclohexyl)methyl)-3-phenylpiperazin-1-yl)-2-(methylsulfonyl)phenyl)methanol::US10144715, Compound 48-26

SMILES CC1(C)CCC(CC1)C(=O)N1CCN(C[C@@H]1c1ccccc1)c1ccc(CCO)c(c1)S(C)(=O)=O

InChI Key InChIKey=MMFGEAJCSXYUPB-RUZDIDTESA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 304631   

TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Vitae Pharmaceuticals

US Patent
LigandPNGBDBM304631((S)-(4-(4-((4,4-dimethylcyclohexyl)methyl)-3-pheny...)
Affinity DataKi:  8nMAssay Description:Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-alpha(Homo sapiens (Human))
Vitae Pharmaceuticals

US Patent
LigandPNGBDBM304631((S)-(4-(4-((4,4-dimethylcyclohexyl)methyl)-3-pheny...)
Affinity DataKi:  39nMAssay Description:Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent